Market News / Story
QNCX — Five proposals passed preliminarily; the adjournment proposal was not presented
Quartr ·
Quartr reports: Stockholders preliminarily approved the PIPE-related share issuances, increase in authorized shares, and both 2026 equity plans. The adjournment proposal was not presented after proposals 1–3 received sufficient votes. Based on Quince Therapeutics, Inc. [QNCX] EGM 2026 Audio Transcript — Oct. 6 2026 This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.